SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction
Combination Will Create a Diversified Leader in Life Sciences Tools
Related news for (LAB)
- Today’s Top Performers: MoBot’s Market Review 08/22/25 09:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/22/25 08:00 AM
- Today’s Top Performers: MoBot’s Market Review 06/23/25 09:00 AM
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- 24/7 Market News Snapshot 23 June, 2025 – Standard BioTools Inc. Common Stock (NASDAQ:LAB)